Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on April 28, 2025

Blue Goat Cyber to Share Critical FDA Cybersecurity Strategies at AMDM 2025 Annual Meeting
Blue Goat Cyber will reveal critical FDA cybersecurity strategies for medical device manufacturers at AMDM 2025, helping accelerate regulatory success. SCOTTSDALE, AZ, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Medical device manufacturers …

Couture Diaper Gown Campaign: Arsahd Baby Diaper Raises Awareness About Toxic Chemicals in Baby Diapers
In collaboration with Celebrity Photographer Janessa Taber, Arsahd's Founder Kerry Meikle wore the couture diaper gown, which has since gone viral. AUBURN, CA, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Arsahd Baby recently commissioned …

New Florida Clinic Offers Faster Autism and ADHD Evaluations for Families in Need
Most ADHD and Autism Evaluations Have a 90 Day Waitlist; That's Not the Case at Verdant Psychology SAINT PETERSBURG, CO, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Verdant Psychology, a telehealth-based psychology practice, is proud to expand …

DCI Dental Center International Offers Personalized Dental Treatment Plans for a Radiant Smile this Summer in Antalya
DCI Dental Center International in Turkey offers VIP dental implant and cosmetic services ANTALYA, ANTALYA, TURKEY, April 28, 2025 /EINPresswire.com/ -- As the summer season approaches, DCI Dental Center International is ready to help patients achieve a …

From Award to Impact: How Ascendo AI’s 2025 Win Is Redefining Service Leadership in a Volatile World
SAN FRANCISCO, CA, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Our AI doesn’t replace people; it equips them to thrive. Ascendo AI’s AI-native platform addresses plummeting customer experience scores, employee burnout, and fragmented tools, …

EricMalley.com Reveals $611 Billion Digital Marketing Inefficiency in TechBullion Feature Article
New Four-Part Series Launches “Spherical Philosophy™” to Transform How Businesses Integrate AI and Geographic Engine Optimization NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Digital marketing expert Eric Malley has published a …

Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has appointed Lyn Cobley to its Board of Directors. Ms. Cobley has been a …

CD Bioparticles Introduces New Range of Kits for Advanced Exosome Labeling & Purification
CD Bioparticles has announced the launch of its new comprehensive line of kits for Exosome Labeling …

CD Bioparticles Announces Custom Synthesis Service for Magnetic Sodium Alginate Hydrogel Particles
CD Bioparticles announces new service for custom synthesis and drug encapsulation of Magnetic Sodium Alginate Hydrogel Particles. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- With years of experience in the pharmaceutical and life …

STEMart Advances Research and Development with Comprehensive Microfluidics Services
STEMart has announced its Microfluidics Service for microfluidics application, device development, and manufacturing. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- STEMart, a US-based provider of comprehensive services for all phases …

Creative Diagnostics Launches Monkeypox Virus Neutralizing Antibody Test Services to Aid in Immune Response Assessment
Creative Diagnostics has announced Monkeypox Virus Neutralizing Antibody Test services for monkeypox research. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- As an expert in providing solutions to assist virology and microbiology …

Creative Diagnostics Introduces Advanced tRNA Modification Detection Solutions to Support Genetic Research
Creative Diagnostics has announced its highly validated antibodies for tRNA Modification Detection. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and …

UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine
LONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Phase 1, first-in-human clinical trial led by …

Telix's Illuccix PSMA-PET Imaging Agent Approved in France
MELBOURNE, Australia, April 29, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET1 imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide …

Vistatec Recognized with Two TITAN Awards for Excellence in Business and Leadership
DUBLIN, IE-D, IRELAND, April 28, 2025 /EINPresswire.com/ -- Vistatec has been awarded two TITAN Awards for achievements in Marketing and Human Resources at the 2025 TITAN Awards. At the TITAN Business Awards, Vistatec was honored with a Gold award for …

ElevateBio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
– Oral and poster presentations will highlight advancements from ElevateBio’s two business units: Life Edit, its gene editing and R…

ARCPOINT REPORTS 2024 YEAR END FINANCIAL RESULTS AND ANNOUNCES MANAGEMENT CHANGE
Greenville, South Carolina, April 28, 2025 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) is pleased to report that it has filed its 2024 year end, audited Financial Statements and related Management Discussion and Analysis as …

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting
WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with …

Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025
NEW YORK, 28 avr. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS - NASDAQ : CLLS) (la "Société"), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome pour développer des thérapies cellulaires …

Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion
Reflects business philosophy of commercial success through patient accessibility Recently executed agreement with CD 8 Technology Services LLC providing up to $50 million for Company’s dedicated R&D and manufacturing facility; no impact on shareholder …